메뉴 건너뛰기




Volumn 46, Issue 22, 2007, Pages 1827-1832

Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C

Author keywords

Chronic hepatitis C; Peginterferon; Ribavirin; Side effects

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; PEGINTERFERON; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

EID: 36749016632     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0289     Document Type: Article
Times cited : (25)

References (17)
  • 1
    • 0035934568 scopus 로고    scopus 로고
    • Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
    • Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358: 958-965, 2001.
    • (2001) Lancet , vol.358 , pp. 958-965
    • Manns, M.P.1    McHutchison, J.G.2    Gordon, S.C.3
  • 2
    • 0037179698 scopus 로고    scopus 로고
    • Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
    • Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347: 975-982, 2002.
    • (2002) N Engl J Med , vol.347 , pp. 975-982
    • Fried, M.W.1    Shiffman, M.L.2    Reddy, K.R.3
  • 3
    • 1542378867 scopus 로고    scopus 로고
    • PEGASYS International Study Group. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose
    • Hadziyannis SJ, Sette H Jr, Morgan TR, et al. PEGASYS International Study Group. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 140: 346-355, 2004.
    • (2004) Ann Intern Med , vol.140 , pp. 346-355
    • Hadziyannis, S.J.1    Sette Jr, H.2    Morgan, T.R.3
  • 4
    • 0030248901 scopus 로고    scopus 로고
    • Side effects of high-dose interferon therapy for chronic hepatitis C
    • Okanoue T, Sakamoto S, Itoh Y, et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 25: 283-291, 1996.
    • (1996) J Hepatol , vol.25 , pp. 283-291
    • Okanoue, T.1    Sakamoto, S.2    Itoh, Y.3
  • 5
    • 0036830454 scopus 로고    scopus 로고
    • Side effects of therapy of hepatitis C and their management
    • Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 36: S237-244, 2002.
    • (2002) Hepatology , vol.36
    • Fried, M.W.1
  • 6
    • 33644804915 scopus 로고    scopus 로고
    • Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C
    • Iwasaki Y, Ikeda H, Arald Y, et al. Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C. Hepatology 43: 54-63, 2006.
    • (2006) Hepatology , vol.43 , pp. 54-63
    • Iwasaki, Y.1    Ikeda, H.2    Arald, Y.3
  • 7
    • 0032801727 scopus 로고    scopus 로고
    • Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis
    • Schalm SW, Weiland O, Hansen BE, et al. Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis. Gastroenterology 117: 408-413, 1999.
    • (1999) Gastroenterology , vol.117 , pp. 408-413
    • Schalm, S.W.1    Weiland, O.2    Hansen, B.E.3
  • 8
    • 0036788338 scopus 로고    scopus 로고
    • International Hepatitis Interventional Therapy Group. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C
    • McHutchison JG, Manns M, Patel K, et al. International Hepatitis Interventional Therapy Group. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 123: 1061-1069, 2002.
    • (2002) Gastroenterology , vol.123 , pp. 1061-1069
    • McHutchison, J.G.1    Manns, M.2    Patel, K.3
  • 9
    • 11144358311 scopus 로고    scopus 로고
    • Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial Group. Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment
    • Shiffinan ML, Di Bisceglie AM, Lindsay KL, et al. Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial Group. Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. Gastroenterology 126: 1015-1023, 2004.
    • (2004) Gastroenterology , vol.126 , pp. 1015-1023
    • Shiffinan, M.L.1    Di Bisceglie, A.M.2    Lindsay, K.L.3
  • 10
    • 33846356749 scopus 로고    scopus 로고
    • Impact of reducing peginterferon alfa-2a and ribavirin dose during refreatment in patients with chronic hepatitis C
    • Shiffman ML, Ghany MG, Morgan TR, et al. Impact of reducing peginterferon alfa-2a and ribavirin dose during refreatment in patients with chronic hepatitis C. Gastroenterology 132: 103-112, 2007.
    • (2007) Gastroenterology , vol.132 , pp. 103-112
    • Shiffman, M.L.1    Ghany, M.G.2    Morgan, T.R.3
  • 11
    • 0031918127 scopus 로고    scopus 로고
    • Multicenter evaluation of the Cobas Amplicor HCV assay, an integrated PCR system for rapid detection of hepatitis C virus RNA in the diagnostic laboratory
    • Albadalejo J, Alonso R, Antinozzi R, et al. Multicenter evaluation of the Cobas Amplicor HCV assay, an integrated PCR system for rapid detection of hepatitis C virus RNA in the diagnostic laboratory. J Clin Microbiol 36: 862-865, 1998.
    • (1998) J Clin Microbiol , vol.36 , pp. 862-865
    • Albadalejo, J.1    Alonso, R.2    Antinozzi, R.3
  • 12
    • 0032947751 scopus 로고    scopus 로고
    • Second generation of the automated Cobas Amplicor HCV assay improves sensitivity of hepatitis C virus RNA detection and yields results that are more clinically relevant
    • Doglio A, Laffont C, Caroli-Bose FX, et al. Second generation of the automated Cobas Amplicor HCV assay improves sensitivity of hepatitis C virus RNA detection and yields results that are more clinically relevant. J Chn Microbiól 37: 1567-1569, 1999.
    • (1999) J Chn Microbiól , vol.37 , pp. 1567-1569
    • Doglio, A.1    Laffont, C.2    Caroli-Bose, F.X.3
  • 13
    • 84989559703 scopus 로고
    • Hepatitis C virus genotypes; an investigation of type-specific differences in geographic origin and disease
    • Dusheiko G, Schmilovitz-Weiss H, Brown D, et al. Hepatitis C virus genotypes; an investigation of type-specific differences in geographic origin and disease. Hepatology 19: 13-18, 1994.
    • (1994) Hepatology , vol.19 , pp. 13-18
    • Dusheiko, G.1    Schmilovitz-Weiss, H.2    Brown, D.3
  • 14
    • 0028235641 scopus 로고
    • Classification of chronic hepatitis: Diagnosis, grading and staging
    • Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19: 1513-1520, 1994.
    • (1994) Hepatology , vol.19 , pp. 1513-1520
    • Desmet, V.J.1    Gerber, M.2    Hoofnagle, J.H.3
  • 15
    • 0041822106 scopus 로고    scopus 로고
    • Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
    • Davis GL, Wong JB, McHutchison JG, et al. Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology 38: 645-652, 2003.
    • (2003) Hepatology , vol.38 , pp. 645-652
    • Davis, G.L.1    Wong, J.B.2    McHutchison, J.G.3
  • 16
    • 33749360440 scopus 로고    scopus 로고
    • Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin
    • Bronowicki JP, Ouzan D, Asselah T, et al. Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin. Gastroenterology 131: 1040-1048, 2006.
    • (2006) Gastroenterology , vol.131 , pp. 1040-1048
    • Bronowicki, J.P.1    Ouzan, D.2    Asselah, T.3
  • 17
    • 33744796300 scopus 로고    scopus 로고
    • A study of low dose peginterferon alpha-2b with ribavirin for the initial treatment of chronic hepatitis C
    • for the New York New England Study Team
    • Krawitt EL, Gordon SR, Grace ND, et al. for the New York New England Study Team. A study of low dose peginterferon alpha-2b with ribavirin for the initial treatment of chronic hepatitis C. Am J Gastroenterol 101: 1268-1273, 2006.
    • (2006) Am J Gastroenterol , vol.101 , pp. 1268-1273
    • Krawitt, E.L.1    Gordon, S.R.2    Grace, N.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.